Announce Date | 05/15/2024 |
EPS Normalized Actual | $0 (Beat by $0.59) |
EPS GAAP Actual | $0 (Beat by $0.59) |
Revenue Actual | $0.008059B |
Revenue Surprise | Beat by $8.059M |
Announce Date | 06/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.34259 |
EPS GAAP Estimate | $1.34259 |
Revenue Estimate | $0.0061565B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | -0.85 | -2.24 | -0.85069 | -0.84945 | 0 |
Dec 2026 | -1.33 | -1.43 | -1.33108 | -1.32914 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.74 | -0.74 | 0.008059B | 55.39% | 8.06M |
FQ4 2021 (Dec 2021) | 0 | 0 | 0B | -INF% | 0M |
FQ3 2021 (Sep 2021) | -1.18 | -1.18 | 0.001213B | -68.34% | 1.21M |
FQ2 2021 (Jun 2021) | -0.99 | -0.99 | 0.005261B | 66.03% | 5.26M |
FQ1 2021 (Mar 2021) | -0.92 | -0.92 | 0.003595B | 53.63% | 3.6M |
FQ4 2020 (Dec 2020) | -1.22769 | -1.22769 | 0.00208B | 13.56% | 2.08M |
FQ3 2020 (Sep 2020) | -0.71 | -0.71 | 0.002042B | 8.52% | 2.04M |
FQ2 2020 (Jun 2020) | -0.68 | -0.68 | 0.001787B | 7.61% | 1.79M |
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
1.34259
Consensus Revenue Estimates
0.0061565B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | -0.17 | -- | -0.18665 | -0.15335 | 0 |
FQ2 2026 (Jun 2026) | -0.18 | -- | -0.19763 | -0.16237 | 0 |
FQ1 2026 (Mar 2026) | -0.21 | -- | -0.23057 | -0.18943 | 0 |
FQ4 2025 (Dec 2025) | -0.11 | -- | -0.11255 | -0.10745 | 0 |
FQ3 2025 (Sep 2025) | -0.11 | -- | -0.11255 | -0.10745 | 0 |
FQ2 2025 (Jun 2025) | -0.13 | -- | -0.13302 | -0.12698 | 0 |
FQ1 2025 (Mar 2025) | -0.14 | -- | -0.14325 | -0.13675 | 0 |
FQ4 2024 (Dec 2024) | -0.205 | -- | -0.20976 | -0.20024 | 0 |
FQ3 2024 (Sep 2024) | 1.54141 | -- | 2.00742 | 1.03956 | 2 |
FQ2 2024 (Jun 2024) | 1.34259 | -- | 1.74849 | 0.90547 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ2 2026 (Jun 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ1 2026 (Mar 2026) | 0.02B | -- | 0.02B | 0.02B | 0 |
FQ4 2025 (Dec 2025) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ3 2025 (Sep 2025) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ2 2025 (Jun 2025) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ1 2025 (Mar 2025) | 0.01B | -- | 0.01B | 0.01B | 0 |
FQ4 2024 (Dec 2024) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ3 2024 (Sep 2024) | 0.01B | -- | 0.01B | 0.01B | 1 |
FQ2 2024 (Jun 2024) | 0.01B | -- | 0.01B | 0.01B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
7
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -0.74 | -0.74 | 100% | |
FQ4 2021 (Dec 2021) | 0 | 0 | NAN% | |
FQ3 2021 (Sep 2021) | -1.18 | -1.18 | 100% | |
FQ2 2021 (Jun 2021) | -0.99 | -0.99 | 100% | |
FQ1 2021 (Mar 2021) | -0.92 | -0.92 | 100% | |
FQ4 2020 (Dec 2020) | -1.22769 | -1.22769 | 100% | |
FQ3 2020 (Sep 2020) | -0.71 | -0.71 | 100% | |
FQ2 2020 (Jun 2020) | -0.68 | -0.68 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.01B | $8.06M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
FQ3 2021 (Sep 2021) | $0B | $0B | $1.21M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.01B | $5.26M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0B | $3.6M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0B | $2.08M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0B | $2.04M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0B | $1.79M | 100% |